2020 Generic and Specialty Drug Companies: Capabilities, Goals and Strategies
NEW YORK, March 31, 2020 /PRNewswire/ -- 2020 Generic and Specialty Drug Companies: Capabilities, Goals and Strategies
Read the full report: https://www.reportlinker.com/p05877558/?utm_source=PRN
In the dynamic and fragmented Generic and Specialty Drug industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketing strategies is particularly important...and can spell the difference between success and failure.
Our collection of strategic assessments of leading Generic and Specialty Drug companies provides significant competitor information, analysis and insight critical to the development and implementation of effective business, marketing and R&D programs. The assessments include latest organizational and management developments, acquisitions and divestitures, marketing tactics, financial results, strengths and weaknesses, and strategic directions.
Aurora Cannabis
Canopy Growth
Cronos Group
Curaleaf
Dr. Reddy's Laboratories
Green Thumb
Merck
MomentaPharma
Mylan
Perrigo
Teva Pharma
Tilray
oetis
These reports will complement your internal competitor information gathering efforts with objective strategic analysis, data interpretation and insight.
The reports will also assist current competitors and potential market entrants in evaluating prospective acquisitions and joint venture candidates.
Read the full report: https://www.reportlinker.com/p05877558/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
View original content:http://www.prnewswire.com/news-releases/2020-generic-and-specialty-drug-companies-capabilities-goals-and-strategies-301032476.html
SOURCE Reportlinker
